Long-term outcome in high-risk corneal transplantation and the influence of HLA-A and HLA-B matching

Cornea

Volumn 22, Issue 6, 2003, Pages 552-556

  Bartels, Marjolijn C ^a   Doxiadis, Ilias I N ^c   Colen, Thomas P ^b   Beekhuis, W Houdijn ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ROTTERDAM EYE HOSPITAL   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cornea; High risk; HLA A; HLA B; Transplantation

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN;

ADOLESCENT; ADULT; AGED; ALLOGRAFT; ARTICLE; CHILD; CORNEA EPITHELIUM; CORNEA TRANSPLANTATION; CYTOTOXIC T LYMPHOCYTE; FEMALE; GRAFT FAILURE; GRAFT REJECTION; GRAFT SURVIVAL; HIGH RISK PATIENT; HLA MATCHING; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; STROMA CELL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CORNEAL TRANSPLANTATION; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY TESTING; HLA-A ANTIGENS; HLA-B ANTIGENS; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 0042845706     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003226-200308000-00013     Document Type: Article

References (30)

1. Vail A, Gore SM, Bradley BA, et al. Conclusions of the corneal transplant follow-up study. Br J Ophthalmol. 1997;81:631-636.
2. Khodadoust AA. The allograft rejection reaction: the leading cause of late failure of clinical corneal grafts. In: Corneal graft failure (Ciba Foundation Symposium). Amsterdam: Elsevier, 1973:151-167.
3. Völker-Dieben HJ, Kok-van Alphen CC, Lansbergen Q, et al. The effect of prospective HLA-A and -B matching on corneal graft survival. Acta Ophthalmol. 1982;60:203-212.
4. Williams KA, Roder D, Esterman A, et al. Factors predictive of corneal graft survival. Ophthalmology. 1992;99:403-444.
5. Boisjoly HM, Tourigny R, Bazir R, et al. Risk factors of corneal graft failure. Ophthalmology. 1993;11:1728-1735.
6. Völker-Dieben HJ, Kok-van Alphen CC, Lansbergen Q, et al. Different influence on corneal graft survival in 539 transplants. Acta Ophthalmol. 1982;60:190-202.
7. Pels E, Van der Gaag R. HLA-A, B, C and HLA-DR antigens and dendritic cells in fresh and organ cultured preserved corneas. Cornea. 1985;3:231-239.
8. Whitsett CF, Stulting RD. The distribution of HLA antigens on human corneal tissue. Invest Ophthalmol Vis Sci. 1984;25:519-524.
9. Li Q, He Y. An immunohistochemical study of Langerhans cells, T-cells and the HLA antigen in human cornea. Yen Ko Hsueh Pao. 1993;19:121-125.
10. Roelen DL, van Beelen E, van Bree SP, et al. The presence of activated donor HLA class I-reactive T lymphocytes is associated with rejection of corneal grafts. Transplantation. 1995;59:1039-1042.
11. The Collaborative Corneal Transplantation Studies. Effectiveness of histocompatibility matching in high risk corneal transplantation. Arch Ophthalmol. 1992;110:1392-1403.
12. Nailpal A, D'Amaro J, Bruning JW, et al. Automated reading of propidium iodide lymphocytotoxicity test for HLA-DR MB MT testing. Tissue Antigens. 1984;24:302.
13. Foulks GN, Sanfillipo F. Beneficial effects of histocompatibility in high-risk corneal transplantation. Am J Ophthalmol. 1982;94:622-629.
14. Sanfilippo F, MacQueen JM, Vaughn WK, et al. Reduced graft rejection with good HLA-A and B matching in high-risk corneal transplantation. N Engl J Med. 1986;1:29-35.
15. Boisjoly HM, Roy R, Bernard P-M, et al. Association between corneal allograft rejections and HLA compatibility. Ophthalmology. 1990;12:1689-1698.
16. Ozdemir O. A prospective study of histocompatibility testing for keratoplasty in high-risk patients. Br J Ophthalmol. 1986;70:183-186.
17. Batchelor JR, Casey TA, Gibbs DC, et al. HLA matching and corneal grafting. Lancet. 1976;1:551-554.
18. Morita N, Munkhbat B, Gansuvd B, et al. Effect of HLA-A and -DPB1 matching in corneal transplantation. Transplant Proc. 1998;30:3491-3492.
19. Munkhbath B, Hagihara M, Sato T, et al. HLA Class II DNA typing using ocular tissue and its usefulness in corneal transplantation. Transplant Proc. 1996;28:1257-1258.
20. Vail A, Gore SM, Bradley BA, et al. Influence of donor and histocompatibility factors on corneal graft outcome. Transplantation. 1994;58:1210-1216.
21. Völker-Dieben HJ, Claas FHJ, Schreuder GMT, et al. Beneficial effect of HLA-DR matching on the survival of corneal allografts. Transplantation. 2000;4:640-648.
22. Bartels MC, Otten HG, Gelderen van BE, et al. Influence of HLA-A, HLA-B and HLA-DR matching on rejection of random corneal grafts using corneal tissue for retrospective DNA HLA typing. Br J Ophthalmol. 2001;85:1341-1346.
23. Vail A, Gore SM, Bradley BA, et al. Corneal graft survival and visual outcome: a multicentre study. Ophthalmology. 1994;101:120-127.
24. Williams KA, Muehlberg SM, Lewis RF, et al. The Australian Corneal Graft Registry 1996 report. Adelaide: Mercury Press, 1997:19.
25. Christo CG, Van Rooy J, Geerards AJ, et al. Suture related complications following keratoplasty: a 5-year retrospective study. Cornea. 2001;20:816-819.
26. Melles GR, Remeyer L, Geerards AJ, et al. The future of lamellar keratoplasty. Curr Opin Ophthalmol. 1999;10:253-259.
27. Waldock A, Cook SD. Corneal transplantation: how successful are we? Br J Ophthalmol. 2000;84:813-815.
28. Hill JC. Systemic cyclosporin in high-risk keratoplasties: short- versus long-term therapy. Ophthalmology. 1994;101:128-133.
29. Hikita N, Lopez JS, Chan C-C, et al. Use of topical FK506 in a corneal graft rejection model in Lewis rats. Invest Ophthalmol Vis Sci. 1997;38:901-909.
30. Lam DSC, Wong AKK, Tham CCY, et al. The use of combined intravenous pulse methylprednisolone and oral cyclosporin A in the treatment of corneal graft rejection: a preliminary study. Eye. 1998;12:615-618.